Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 7893

1.

Risk Factors for Barrett's Oesophagus.

Sharma N, Ho KY.

Gastrointest Tumors. 2016 Oct;3(2):103-108. Review.

2.
3.

Methylome Analysis of Two Xanthomonas spp. Using Single-Molecule Real-Time Sequencing.

Seong HJ, Park HJ, Hong E, Lee SC, Sul WJ, Han SW.

Plant Pathol J. 2016 Dec;32(6):500-507.

4.

Microscopic colitis in patients with mild duodenal damage: A new clinical and pathological entity ("lymphocytic enterocolitis")?

Bonagura GA, Ribaldone DG, Fagoonee S, Sapone N, Caviglia GP, Saracco GM, Astegiano M, Pellicano R.

World J Gastrointest Pathophysiol. 2016 Nov 15;7(4):307-313.

5.

Anti-<i>Helicobacter pylori</i> effect of CaG-NANA, a new sialic acid derivative.

Rhee YH, Ku HJ, Noh HJ, Cho HH, Kim HK, Ahn JC.

World J Gastrointest Pathophysiol. 2016 Nov 15;7(4):300-306.

6.

Is it necessary to screen <i>Helicobacter pylori</i> infection in patients with celiac disease and iron deficiency?

Samasca G, Deleanu D, Sur G, Lupan I, Giulia A, Carpa R.

Gastroenterol Hepatol Bed Bench. 2016 Fall;9(4):345. No abstract available.

7.

High PARP-1 expression is associated with tumor invasion and poor prognosis in gastric cancer.

Liu Y, Zhang Y, Zhao Y, Gao D, Xing J, Liu H.

Oncol Lett. 2016 Nov;12(5):3825-3835.

8.

Molecular detection of <i>Helicobacter pylori</i> antibiotic resistance in stool <i>vs</i> biopsy samples.

Brennan DE, Omorogbe J, Hussey M, Tighe D, Holleran G, O'Morain C, Smith SM, McNamara D.

World J Gastroenterol. 2016 Nov 7;22(41):9214-9221.

9.

Characteristics of gastric cancer detected within 1 year after successful eradication of <i>Helicobacter pylori</i>.

Nishizawa T, Suzuki H, Arano T, Yoshida S, Yamashita H, Hata K, Kanai T, Yahagi N, Toyoshima O.

J Clin Biochem Nutr. 2016 Nov;59(3):226-230.

10.

Expression of Alpha Methylacyl CoA Racemase (AMACR) in Gastric Adenocarcinoma and Its Correlation with <i>Helicobacter pylori</i> Infection.

Jindal Y, Singh A, Kumar R, Varma K, Misra V, Misra SP, Dwivedi M.

J Clin Diagn Res. 2016 Oct;10(10):EC10-EC12.

11.

Comparative Analysis of Two <i>Helicobacter pylori</i> Strains using Genomics and Mass Spectrometry-Based Proteomics.

Karlsson R, Thorell K, Hosseini S, Kenny D, Sihlbom C, Sjöling Å, Karlsson A, Nookaew I.

Front Microbiol. 2016 Nov 11;7:1757.

12.

Eradication of <i>Helicobacter pylori</i> Infection Restores ki67, p53, and Cyclin D1 Immunoreactivity in the Human Gastric Epithelium.

Triantafyllou K, Papadopoulos V, Emanouil T, Gkolfakis P, Damaskou V, Tziatzios G, Panayiotides IG, Vafiadis I, Ladas SD.

Clin Med Insights Gastroenterol. 2016 Nov 17;9:73-78.

13.

Analysis of <i>Helicobacter pylori</i> Prevalence in Chittagong, Bangladesh, Based on PCR and CLO Test.

Habib AM, Alam MJ, Rudra B, Quader MA, Al-Forkan M.

Microbiol Insights. 2016 Nov 17;9:47-50.

14.

Diversification of the <i>vacAs1m1</i> and <i>vacAs2m2</i> Strains of <i>Helicobacter pylori</i> in <i>Meriones unguiculatus</i>.

Mendoza-Elizalde S, Arteaga-Resendiz NK, Valencia-Mayoral P, Luna RC, Moreno-Espinosa S, Arenas-Huertero F, Zúñiga G, Velázquez-Guadarrama N.

Front Microbiol. 2016 Nov 8;7:1758.

15.

Importance of the C-terminal histidine residues of Helicobacter pylori GroES for Toll-like receptor 4 binding and interleukin-8 cytokine production.

Lee H, Su YL, Huang BS, Hsieh FT, Chang YH, Tzeng SR, Hsu CH, Huang PT, Lou KL, Wang YT, Chow LP.

Sci Rep. 2016 Nov 21;6:37367. doi: 10.1038/srep37367.

16.

Usefulness of vonoprazan, a potassium ion-competitive acid blocker, for primary eradication of <i>Helicobacter pylori</i>.

Yamada S, Kawakami T, Nakatsugawa Y, Suzuki T, Fujii H, Tomatsuri N, Nakamura H, Sato H, Okuyama Y, Kimura H, Yoshida N.

World J Gastrointest Pharmacol Ther. 2016 Nov 6;7(4):550-555.

17.

Addition of cranberry to proton pump inhibitor-based triple therapy for <i>Helicobacter pylori</i> eradication.

Seyyedmajidi M, Ahmadi A, Hajiebrahimi S, Seyedmajidi S, Rajabikashani M, Firoozabadi M, Vafaeimanesh J.

J Res Pharm Pract. 2016 Oct-Dec;5(4):248-251.

18.

The Role of <i>H. pylori</i> CagA in Regulating Hormones of Functional Dyspepsia Patients.

Meng WP, Wang ZQ, Deng JQ, Liu Y, Deng MM, Lü MH.

Gastroenterol Res Pract. 2016;2016:7150959. Review.

19.

Differences in amino acid frequency in CagA and VacA sequences of <i>Helicobacter pylori</i> distinguish gastric cancer from gastric MALT lymphoma.

Hashinaga M, Suzuki R, Akada J, Matsumoto T, Kido Y, Okimoto T, Kodama M, Murakami K, Yamaoka Y.

Gut Pathog. 2016 Nov 8;8:54.

Items per page

Supplemental Content

Loading ...
Support Center